Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.

Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, Akaza H, Bossi A, van Veenhuyzen DF, Selby B, Fan X, Kang V, Walling J, Tombal B, HERO Study Investigators

Open source

DOI: 10.1056/nejmoa2004325
Published: 2020 Jun 4
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2004325,
  title = {Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.},
  author = {Shore ND and Saad F and Cookson MS and George DJ and Saltzstein DR and Tutrone R and Akaza H and Bossi A and van Veenhuyzen DF and Selby B and Fan X and Kang V and Walling J and Tombal B and HERO Study Investigators},
  year = {2020},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2004325},
  url = {https://doi.org/10.1056/nejmoa2004325}
}

RIS

TY  - JOUR
TI  - Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
AU  - Shore ND
AU  - Saad F
AU  - Cookson MS
AU  - George DJ
AU  - Saltzstein DR
AU  - Tutrone R
AU  - Akaza H
AU  - Bossi A
AU  - van Veenhuyzen DF
AU  - Selby B
AU  - Fan X
AU  - Kang V
AU  - Walling J
AU  - Tombal B
AU  - HERO Study Investigators
PY  - 2020
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2004325
UR  - https://doi.org/10.1056/nejmoa2004325
ER  -

APA

ND, S., F, S., MS, C., DJ, G., DR, S., R, T., H, A., A, B., DF, V. V., B, S., X, F., V, K., J, W., B, T., & Investigators, H. S. (2020). Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2004325

Source records

pubmed · retrieved 2026-09-27T00:15:15.017Z